Please try another search
Oncology Pharma, Inc. is an oncology company. The Company is focused on licensing, developing, manufacturing and commercializing therapeutics. The Company’s research, development, and commercialization of therapeutic drugs and medical devices designed for the treatment of many types of cancers. The Company offers a portfolio, such as Nanosmart Pharmaceuticals Inc. (Nanosmart Pharmaceuticals). The Company’s NanoSmart platform technology is a human-derived, antinuclear antibody (ANA) that targets areas of necrosis present in solid tumors. Its anti-cancer drugs in combination with medications, for treating a variety of cancers, such as breast, ovarian, lung, bladder, Kaposi's sarcoma, lymphoma and acute lymphocytic leukemia is doxorubicin. Its portfolio also includes Connect2Med, Sybleu, Inc. and Regen.
Name | Age | Since | Title |
---|---|---|---|
Chuck Wagner | - | 2014 | President, Treasurer & Chairman |
Shawn Thomas Crouse | - | - | Independent Director |
Stefan Gruenwald | - | 2019 | Member of Advisory Board & Independent Director |
Carlos Barnett | - | - | Independent Director |
James Smith | - | - | Member of Advisory Board |
Argyrios Theofilopoulos | - | - | Member of Scientific Advisory Board |
Henry J. Smith | 82 | 2021 | Chairman of the Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review